Taitel Haya

SEC Form 4 insider trading activity

Taitel Haya has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 7, 2026.

On the most recent filing, Taitel Haya is listed as Director at Entera Bio Ltd. Inside the rolling window, Taitel Haya reported 1 open-market purchase totaling $11K in ENTX and no open-market sales.

Companies traded

Other insiders at ENTX

Insider Buying

$11K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ENTX
Taitel Haya
Purchase$11KFeb 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Taitel Haya made?

Taitel Haya has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.

Which companies does Taitel Haya trade?

Taitel Haya has filed SEC Form 4 disclosures for 1 company, including ENTX.

When was Taitel Haya's most recent SEC Form 4 filing?

Taitel Haya's most recent SEC Form 4 filing on Tracefour is dated Aug 7, 2026.

What is Taitel Haya's total buy and sell value in the current window?

Inside the rolling retention window, Taitel Haya bought $11K and sold $0 based on SEC Form 4 filings.

What was Taitel Haya's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 7,500 ENTX shares on 2026-02-10, worth $11K, per SEC Form 4 filings.